Table 2. Distribution of breast cancer patients according to pathological characteristics.
| Pathological features | Breast cancer | |
|---|---|---|
| n | % | |
| Tumour grade | ||
| I | 04 | 13.3 |
| II | 12 | 40.0 |
| III | 14 | 46.7 |
| Tumour size | ||
| < 2 cm | 12 | 40 |
| ≥ 2 cm | 18 | 60 |
| Histologycal type | ||
| Ductal in situ | 01 | 3.3 |
| Invasive ductal | 29 | 96.7 |
| Hormone receptor status | ||
| ER | ||
| Positive | 15 | 50 |
| Negative | 15 | 50 |
| PR | ||
| Positive | 17 | 56.7 |
| Negative | 13 | 43.3 |
| HER2 | ||
| Positive | 6 | 20 |
| Negative | 24 | 80 |
| Molecular subtypes | ||
| Luminal A | 03 | 10.0 |
| Luminal B | 16 | 53.3 |
| HER2+ | 03 | 10.0 |
| Triple negative | 08 | 26.7 |
Abbreviations: ER: estrogen receptor, PR: progesterone receptor, HER2: human epidermal growth factor receptor-type 2.